Call for Nominations for the 2024 CIHR-ICRH/CSATVB Mid-Career Excellence Award in Blood and Blood Vessel Research

The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH) and the Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology (CSATVB) have partnered on the 2024 CIHR-ICRH/CSATVB Mid-Career Excellence Award in Blood and Blood Vessel Research. The establishment of this annual partnered award is to recognize an individual's outstanding contribution to the advancement of blood and blood vessels in Canada at the mid-point of their career. The award will be presented to the selected candidate annually at the Canadian Lipid and Vascular Summit (CLVS), where the recipient will give a lecture as part of the scientific program. The CLVS is a joint scientific symposium of the CSATVB and the Canadian Lipoprotein Conference.

The selected candidate will be an outstanding mid-career investigator (at the time of application, has assumed his/her independent research position 5-15 years ago) who has conducted the majority of their research in Canada and has contributed significantly to the advancement of blood and blood vessel sciences in Canada and/or internationally. For the 2024 competition, the eligibility time frame is adjusted by 1 year to account for productivity losses as a result of the COVID-19 pandemic. As such, the eligibility time frame is from 6-16 years ago. For all competitions, we will account for all disclosed leaves (i.e. parental, medical, and family responsibility leave) when calculating career stage.

The individual may have conducted work in any one of a number of blood science disciplines and within any of the four CIHR research theme areas: biomedical; clinical; health systems and services; and social, cultural, environmental, and population health. The successful candidate's research should also be aligned with the interests of CSATVB and CIHR-ICRH.

The award consists of a $5,000 honorarium in addition to reimbursement of eligible expenses (e.g., travel, accommodations, registration fees) for the recipient to attend CLVS 2024 and to deliver a lecture on a research topic relevant to a broad research audience.

Please complete the standardized nomination form [ PDF (212 KB) ] and submit it by e-mail at by 4:00 pm MT on April 23, 2024.

CIHR and CSATVB recognize the importance and need for diversity within health research. We encourage nominations for outstanding scientists who are women, Indigenous Peoples (First Nations, Inuit, and Métis), members of racialized communities, persons with disabilities, 2SLGBTQIA+ persons, and others who contribute to the further diversification of ideas.

Please note that only one nomination for an individual is permitted and multiple nominations for an individual will not be accepted. Scientists who have received a CIHR-ICRH partnered Mid-Career Lecturer Award previously are not eligible for nomination. Nominations for candidates not selected may be carried forward for consideration for up to three (3) consecutive years from the original nomination year, and the nominator may be contacted to update the nomination package.

Please consider the CIHR-ICRH Strategic Priorities (Preparing Future Capacity, Accelerating Knowledge Through Collaboration, Catalyzing Impact Through Knowledge Mobilization) and Foundational Themes (Strengthening Indigenous Health Research, Enhancing Equity, Diversity, and Inclusion in Health Research) when reflecting the nominees impacts against the below evaluation criteria. For more information, please view the CIHR-ICRH Strategic Plan 2022–2025.

Nominations will be assessed against the following evaluation criteria:

  1. Impact of nominee's research on blood and/or blood vessel sciences both in Canada and internationally; extent to which the nominee has contributed significantly to the advancement of blood sciences both in Canada and internationally (e.g., important/key research results or findings) over the last ten years.
  2. Relevance/application/impact of nominee's research to a clinical outcomes, new IP, or other important breakthroughs in the field of blood and blood vessel sciences.
  3. Demonstrated strength and reputation of the proposed nominee in the field of blood and/or blood vessel sciences in Canada and internationally.
  4. Impact of the nominee's mentorship and training environment on the development of early career scientists and other highly qualified personnel in Canada and internationally.
Date modified: